Funded Tech Companies
Glox Therapeutics
Researching who provided funding to Glox Therapeutics? Scottish Enterprise and Boehringer Ingelheim Venture Fund joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Glox Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
11 The Square University Of Glasgow University Avenue
Glasgow, Scotland, G12 8QQ
UK
Glasgow, Scotland, G12 8QQ
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Glox Therapeutics was founded by Professor Daniel Walker, Professor Colin Kleanthous and Dr James Clark in February 2023 to exploit recent advances in understanding bacteriocin structure and mode of action made in the laboratories of Professors Walker and Kleanthous at the University of Glasgow and University of Oxford, respectively.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/14/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Clark
Chief Scientific Officer
Daniel Walker
Company Investors
- Scottish Enterprise
- Boehringer Ingelheim Venture Fund
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs